Effect of PEEP on Lung Regional Ventilation and Perfusion (PEEP)

July 12, 2020 updated by: Yun Long

Effect of Positive End-expiratory Pressure(PEEP) on Regional Ventilation and Perfusion Estimated by Indicator-based Electrical Impedance Tomography(EIT) Method in Critically Ill Patients With Mechanical Ventilation

Investigate effects of PEEP on pulmonary regional ventilation and perfusion assessed by EIT

Study Overview

Detailed Description

  1. When the research team was available, adult patients within 7days who were sequentially admitted to the Department of Critical Care Medicine and required central venous catheters and mechanically ventilation were eligible for the study.
  2. Written informed consent was obtained from all patients or next of kin before data were included in the study.
  3. Information collected at enrollment included demographic characteristics, such as age, sex.
  4. The blood pressure(BP),heart rate(HR), pulse O2(SpO2),tidal volume and lung regional ventilation and perfusion were collected at PEEP 0 centimeter H2O column and PEEP 12-15 centimeter H2O column.
  5. Indicator-based EIT method: rapidly inject 10ml 10% Sodium chloride(NaCL) through central venous catheter during a 8s respiratory hold, and the curve of impedence change was collected by EIT machine

Study Type

Observational

Enrollment (Actual)

33

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China
        • Peking Union Medical College Hospital, Chinese Academy of Medical Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

adult patients within 7 days, who were sequentially admitted to the Department of Critical Care Medicine and required central venous catheters and mechanically ventilation were eligible for the study

Description

Inclusion Criteria:

  1. have been placed central venous catheter based on patient's condition
  2. Under mechanically ventilation
  3. Under sedation and control ventilation mode
  4. Year>18

Exclusion Criteria:

  1. Pneumothorax
  2. pregnancy
  3. Severe chest wall wound
  4. Severe hypernatremia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
lung regional ventilation distribution
Time Frame: Hour 1
lung regional ventilation distribution measured by EIT
Hour 1
lung regional perfusion distribution
Time Frame: Hour 1
lung regional perfusion distribution measured by EIT
Hour 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Yun Long, Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

May 28, 2020

Study Completion (Actual)

June 1, 2020

Study Registration Dates

First Submitted

September 3, 2019

First Submitted That Met QC Criteria

September 4, 2019

First Posted (Actual)

September 9, 2019

Study Record Updates

Last Update Posted (Actual)

July 14, 2020

Last Update Submitted That Met QC Criteria

July 12, 2020

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypoxia

3
Subscribe